Prospective Randomized Evaluation of Implantable Cardioverter‐Defibrillator Programming in Patients With a Left Ventricular Assist Device

Background Ventricular arrhythmias are common in patients with left ventricular assist devices (LVADs) but are often hemodynamically tolerated. Optimal implantable cardioverter defibrillator (ICD) tachy‐programming strategies in patients with LVAD have not been determined. We sought to determine if an ultra‐conservative ICD programming strategy in patients with LVAD affects ICD shocks. Methods and Results Adult patients with an existing ICD undergoing continuous flow LVAD implantation were randomized to standard ICD programming by their treating physician or an ultra‐conservative ICD programming strategy utilizing maximal allowable intervals to detection in the ventricular fibrillation and ventricular tachycardia zones with use of ATP. Patients with cardiac resynchronization therapy (CRT) devices were also randomized to CRT ON or OFF. Patients were followed a minimum of 6 months. The primary outcome was time to first ICD shock. Among the 83 patients studied, we found no statistically significant difference in time to first ICD shock or total ICD shocks between groups. In the ultra‐conservative group 16% of patients experienced at least one shock compared with 21% in the control group (P=0.66). There was no difference in mortality, arrhythmic hospitalization, or hospitalization for heart failure. In the 41 patients with CRT ICDs fewer shocks were observed with CRT‐ON but this was not statistically significant: 10% of patients with CRT‐ON (n=21) versus 38% with CRT‐OFF (n=20) received shocks (P=0.08). Conclusions An ultra‐conservative programming strategy did not reduce ICD shocks. Programming restrictions on ventricular tachycardia and ventricular fibrillation zone therapy should be reconsidered for the LVAD population. The role of CRT in patients with LVAD warrants further investigation. Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT01977703.

[1]  V. Kutyifa Is there a need for an implantable cardioverter defibrillator in patients with left ventricular assist devices? Time for MADIT-VAD! , 2017, Expert review of medical devices.

[2]  R. Kociol Time for MADIT-VAD?: ICDs Among LVAD Patients. , 2016, JACC. Heart failure.

[3]  I. Anand,et al.  Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. , 2016, JACC. Heart failure.

[4]  S. Cha,et al.  Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation. , 2016, The American journal of cardiology.

[5]  N. Kman,et al.  Clinical Communications : Adults ASYMPTOMATIC SUSTAINED POLYMORPHIC VENTRICULAR TACHYCARDIA IN A PATIENT WITH A LEFT VENTRICULAR ASSIST DEVICE : CASE REPORT AND WHAT THE EMERGENCY PHYSICIAN SHOULD KNOW , 2022 .

[6]  F. Sacher,et al.  Management of Ventricular Arrhythmias in Patients with Mechanical Ventricular Support Devices , 2015, Current Cardiology Reports.

[7]  M. Slaughter,et al.  Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. , 2015, Journal of cardiac failure.

[8]  W. Saliba,et al.  Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study). , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  Marc A Miller,et al.  The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices , 2013, Circulation. Arrhythmia and electrophysiology.

[10]  N. Uriel,et al.  Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? , 2013, Journal of the American College of Cardiology.

[11]  Nader Moazami,et al.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[13]  Paul J. Wang,et al.  Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). , 2011, Journal of the American College of Cardiology.

[14]  L. Allen,et al.  Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  N. Smedira,et al.  Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator. , 2010, Heart rhythm.

[16]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[17]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[18]  J. Towbin,et al.  International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[20]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[21]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[22]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[23]  M. Oz,et al.  Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. , 1994, Journal of the American College of Cardiology.

[24]  N Engl,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. , 1997, Circulation.